Trial intelligence / Profile preview

Topiramate in Male Abdominal Obesity

NCT00231608Phase 2Completed

Sponsor
Johnson & Johnson
Start
Dec 1998
Modality
Small Molecules
01

Overview

A Phase 2 trial of topiramate in obesity, sponsored by Johnson & Johnson. Started Dec 1998; status: completed.

02

Drugs

topiramate
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00231608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00231608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call